标题
Current and emerging therapeutic targets for IBD
作者
关键词
-
出版物
Nature Reviews Gastroenterology & Hepatology
Volume 14, Issue 5, Pages 269-278
出版商
Springer Nature
发表日期
2017-02-01
DOI
10.1038/nrgastro.2016.208
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice
- (2017) Vanessa Popp et al. GASTROENTEROLOGY
- Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
- (2016) A. Stallmach et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium
- (2016) Parambir S Dulai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases
- (2016) Hannah A. Blair et al. BIODRUGS
- Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases
- (2016) Emma D. Deeks BIODRUGS
- Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism
- (2016) I Oancea et al. GUT
- Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases
- (2016) Imke Atreya et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- Changes in Biosimilar Knowledge among European Crohn’s Colitis Organization [ECCO] Members: An Updated Survey
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
- (2016) Julián Panés et al. LANCET
- Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
- (2016) David R Withers et al. NATURE MEDICINE
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
- (2016) Penelope Pelczar et al. SCIENCE
- Role and mechanisms of action ofEscherichia coliNissle 1917 in the maintenance of remission in ulcerative colitis patients: An update
- (2016) Franco Scaldaferri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial
- (2016) Mariano García-Arranz et al. Stem Cells Translational Medicine
- Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
- (2016) Julian Borchardt et al. Multiple Sclerosis and Related Disorders
- Late-breaking abstracts
- (2016) United European Gastroenterology Journal
- Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
- (2016) Kenji Suzuki et al. PLoS One
- Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis
- (2015) Prashant Nighot et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
- (2015) Melinda Gooderham et al. BIODRUGS
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease
- (2015) Paolo Biancheri et al. GASTROENTEROLOGY
- Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease
- (2015) Ilse Molendijk et al. GASTROENTEROLOGY
- Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study
- (2015) Walter Reinisch et al. GUT
- Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
- (2015) Robert V Bryant et al. GUT
- Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
- (2015) Anika Fischer et al. GUT
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
- (2015) Joseph R. Maxwell et al. IMMUNITY
- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
- (2015) Norbert Krug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
- (2015) Giovanni Monteleone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact
- (2015) Rachele Ciccocioppo et al. Stem Cell Research & Therapy
- Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
- (2015) Derek C. Marshall et al. PLoS One
- Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis
- (2014) Stefanie Steiner et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
- (2014) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
- (2014) Malgorzata Matusiewicz et al. DISEASE MARKERS
- Update on Janus Kinase Antagonists in Inflammatory Bowel Disease
- (2014) Brigid S. Boland et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
- (2014) Silvio Danese et al. GUT
- Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
- (2014) Tim Wyant et al. GUT
- Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies
- (2014) Mindy CW Lam et al. Immunotherapy
- 6-Mercaptopurine Reduces Macrophage Activation and Gut Epithelium Proliferation Through Inhibition of GTPase Rac1
- (2014) Goran Marinković et al. INFLAMMATORY BOWEL DISEASES
- Inhibitors of phosphodiesterase 4 (PDE 4): A new therapeutic option in the treatment of psoriasis vulgaris and psoriatic arthritis
- (2014) Małgorzata Mazur et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells
- (2014) Katharina Gerlach et al. NATURE IMMUNOLOGY
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- Adalimumab Induces Deep Remission in Patients With Crohn's Disease
- (2013) Jean–Frédéric Colombel et al. Clinical Gastroenterology and Hepatology
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
- (2013) Robert H. Oakley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism
- (2013) A Eken et al. Mucosal Immunology
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
- (2013) A. E. Dorofeyev et al. Gastroenterology Research and Practice
- Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
- (2012) I. Monteleone et al. CURRENT MOLECULAR MEDICINE
- Autologous Expanded Adipose-Derived Stem Cells for the Treatment of Complex Cryptoglandular Perianal Fistulas
- (2012) M.D. Herreros et al. DISEASES OF THE COLON & RECTUM
- Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
- (2012) Pierre Desreumaux et al. GASTROENTEROLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Mucosal healing in inflammatory bowel diseases: a systematic review
- (2012) Markus F Neurath et al. GUT
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohn's Disease
- (2011) Sergio Rutella et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Th17-related cytokines: new players in the control of chronic intestinal inflammation
- (2011) Ivan Monteleone et al. BMC Medicine
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- (2011) Jean Frédéric Colombel et al. GASTROENTEROLOGY
- Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
- (2011) Raja Atreya et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- New therapies for inflammatory bowel disease: from the bench to the bedside
- (2011) Silvio Danese GUT
- Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change
- (2011) I. Ordas et al. GUT
- Toll-like receptor-7 ligand imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis
- (2011) Satheesh K. Sainathan et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
- (2011) Alessandra Geremia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulated IL-7 Receptor Expression on Colitogenic Memory CD4+ T Cells May Participate in the Development and Persistence of Chronic Colitis
- (2011) T. Shinohara et al. JOURNAL OF IMMUNOLOGY
- Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
- (2011) Claudia Günther et al. NATURE
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Effects of TNF (TNFSF2) and IFN-γ on Intestinal Epithelial Cell Morphogenesis and Barrier Function in Three-Dimensional Culture
- (2011) Kati Juuti-Uusitalo et al. PLoS One
- Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
- (2010) Daniela De Nitto et al. CURRENT PHARMACEUTICAL DESIGN
- Phosphatidylcholine (Lecithin) and the Mucus Layer: Evidence of Therapeutic Efficacy in Ulcerative Colitis?
- (2010) Wolfgang Stremmel et al. DIGESTIVE DISEASES
- Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
- (2010) Anne Christine W. Vos et al. GASTROENTEROLOGY
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting the response to infliximab from trough serum levels
- (2009) P. Rutgeerts et al. GUT
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
- (2009) Geethanjali Pickert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation
- (2009) Amit Awasthi et al. NATURE IMMUNOLOGY
- F1C Fimbriae Play an Important Role in Biofilm Formation and Intestinal Colonization by the Escherichia coli Commensal Strain Nissle 1917
- (2008) M. A. Lasaro et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis
- (2008) Ashley J. Snider et al. FASEB JOURNAL
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
- (2008) Moritz Leppkes et al. GASTROENTEROLOGY
- IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
- (2008) T Kobayashi et al. GUT
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- TGF-β1 and Smad7 in the regulation of IBD
- (2008) G Monteleone et al. Mucosal Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More